Recommendation: HV
Current Price: $197.28
Total Wheels: 14
EditTypically you want to choose options that have a higher than 70% chance of being out of the money, since then you only have a 30% chance of actually acquiring the stock. Beyond that maximumizing the annualized rate of return is a good idea.
Annualized rate of return is computed fairly bullish as (max_return * odds + (1 - odds)) ^ (252 / calendar_days). This assumes that if you accidently acquire the stock you will be able to do something such that effectively get you a 1x return immediately.
| Ticker | Strike | Premium | Ticker Price | Calendar Days To Expiration | Odds Out Of The Money % | Maximum Return % | Annualized Rate Of Return |
|---|---|---|---|---|---|---|---|
| MRNA | 195.0 | 6.2 | 197.28 | 5 (2026-10-02) | 56.84% | 3.18% | 2.47x |
| MRNA | 192.5 | 5.0 | 197.28 | 5 (2026-10-02) | 62.38% | 2.60% | 2.25x |
| MRNA | 190.0 | 4.1 | 197.28 | 5 (2026-10-02) | 67.50% | 2.16% | 2.07x |
| MRNA | 195.0 | 9.65 | 197.28 | 10 (2026-10-09) | 56.17% | 4.95% | 2.00x |
| MRNA | 187.5 | 3.23 | 197.28 | 5 (2026-10-02) | 72.53% | 1.72% | 1.87x |
| MRNA | 195.0 | 21.5 | 197.28 | 25 (2026-10-30) | 57.45% | 11.03% | 1.86x |
| MRNA | 192.5 | 7.85 | 197.28 | 10 (2026-10-09) | 60.10% | 4.08% | 1.84x |
| MRNA | 195.0 | 24.5 | 197.28 | 30 (2026-11-06) | 58.04% | 12.56% | 1.81x |
| MRNA | 190.0 | 18.7 | 197.28 | 25 (2026-10-30) | 60.91% | 9.84% | 1.80x |
| MRNA | 190.0 | 6.88 | 197.28 | 10 (2026-10-09) | 63.84% | 3.62% | 1.78x |
| MRNA | 195.0 | 12.05 | 197.28 | 15 (2026-10-16) | 56.19% | 6.18% | 1.77x |
| MRNA | 187.5 | 6.12 | 197.28 | 10 (2026-10-09) | 67.28% | 3.26% | 1.73x |
| MRNA | 185.0 | 5.73 | 197.28 | 10 (2026-10-09) | 70.06% | 3.10% | 1.72x |
| MRNA | 190.0 | 9.84 | 197.28 | 15 (2026-10-16) | 62.09% | 5.18% | 1.70x |
| MRNA | 180.0 | 14.05 | 197.28 | 25 (2026-10-30) | 67.87% | 7.81% | 1.68x |
| MRNA | 185.0 | 2.48 | 197.28 | 5 (2026-10-02) | 77.34% | 1.34% | 1.68x |
| MRNA | 195.0 | 14.38 | 197.28 | 20 (2026-10-23) | 56.38% | 7.37% | 1.67x |
| MRNA | 192.5 | 9.95 | 197.28 | 15 (2026-10-16) | 59.37% | 5.17% | 1.66x |
| MRNA | 175.0 | 12.6 | 197.28 | 25 (2026-10-30) | 71.01% | 7.20% | 1.65x |
| MRNA | 195.0 | 25.93 | 197.28 | 40 (2026-11-20) | 58.35% | 13.30% | 1.60x |
| MRNA | 185.0 | 7.65 | 197.28 | 15 (2026-10-16) | 67.96% | 4.14% | 1.59x |
| MRNA | 187.5 | 7.95 | 197.28 | 15 (2026-10-16) | 65.56% | 4.24% | 1.59x |
| MRNA | 190.0 | 23.18 | 197.28 | 40 (2026-11-20) | 61.23% | 12.20% | 1.57x |
| MRNA | 175.0 | 13.75 | 197.28 | 30 (2026-11-06) | 70.56% | 7.86% | 1.57x |
| MRNA | 185.0 | 20.75 | 197.28 | 40 (2026-11-20) | 64.12% | 11.22% | 1.55x |
| MRNA | 182.5 | 1.92 | 197.28 | 5 (2026-10-02) | 81.46% | 1.05% | 1.54x |
| MRNA | 180.0 | 18.75 | 197.28 | 40 (2026-11-20) | 66.96% | 10.42% | 1.53x |
| MRNA | 177.5 | 8.15 | 197.28 | 20 (2026-10-23) | 72.50% | 4.59% | 1.51x |
| MRNA | 175.0 | 16.2 | 197.28 | 40 (2026-11-20) | 69.85% | 9.26% | 1.48x |
| MRNA | 180.0 | 3.63 | 197.28 | 10 (2026-10-09) | 77.58% | 2.02% | 1.48x |
| MRNA | 180.0 | 5.75 | 197.28 | 15 (2026-10-16) | 73.70% | 3.19% | 1.48x |
| MRNA | 180.0 | 7.66 | 197.28 | 20 (2026-10-23) | 71.49% | 4.26% | 1.46x |
| MRNA | 195.0 | 29.87 | 197.28 | 60 (2026-12-18) | 59.24% | 15.32% | 1.44x |
| MRNA | 170.0 | 13.93 | 197.28 | 40 (2026-11-20) | 72.73% | 8.19% | 1.44x |
| MRNA | 160.0 | 8.8 | 197.28 | 30 (2026-11-06) | 79.22% | 5.50% | 1.43x |
| MRNA | 177.5 | 5.0 | 197.28 | 15 (2026-10-16) | 76.25% | 2.82% | 1.43x |
| MRNA | 190.0 | 27.15 | 197.28 | 60 (2026-12-18) | 61.74% | 14.29% | 1.43x |
| MRNA | 177.5 | 3.13 | 197.28 | 10 (2026-10-09) | 80.25% | 1.76% | 1.42x |
| MRNA | 185.0 | 24.52 | 197.28 | 60 (2026-12-18) | 64.24% | 13.25% | 1.41x |
| MRNA | 180.0 | 1.44 | 197.28 | 5 (2026-10-02) | 85.24% | 0.80% | 1.41x |
| MRNA | 165.0 | 11.75 | 197.28 | 40 (2026-11-20) | 75.64% | 7.12% | 1.39x |
| MRNA | 180.0 | 22.05 | 197.28 | 60 (2026-12-18) | 66.75% | 12.25% | 1.39x |
| MRNA | 175.0 | 6.1 | 197.28 | 20 (2026-10-23) | 76.04% | 3.49% | 1.39x |
| MRNA | 175.0 | 20.38 | 197.28 | 60 (2026-12-18) | 69.17% | 11.65% | 1.38x |
| MRNA | 175.0 | 4.25 | 197.28 | 15 (2026-10-16) | 78.97% | 2.43% | 1.38x |
| MRNA | 160.0 | 10.46 | 197.28 | 40 (2026-11-20) | 78.07% | 6.54% | 1.37x |
| MRNA | 190.0 | 31.47 | 197.28 | 80 (2027-01-15) | 62.42% | 16.56% | 1.36x |
| MRNA | 185.0 | 29.36 | 197.28 | 80 (2027-01-15) | 64.66% | 15.87% | 1.36x |
| MRNA | 175.0 | 2.55 | 197.28 | 10 (2026-10-09) | 83.11% | 1.46% | 1.35x |
| MRNA | 170.0 | 17.6 | 197.28 | 60 (2026-12-18) | 71.72% | 10.35% | 1.35x |
| MRNA | 180.0 | 26.3 | 197.28 | 80 (2027-01-15) | 66.79% | 14.61% | 1.34x |
| MRNA | 155.0 | 8.79 | 197.28 | 40 (2026-11-20) | 80.70% | 5.67% | 1.33x |
| MRNA | 165.0 | 15.3 | 197.28 | 60 (2026-12-18) | 74.22% | 9.27% | 1.32x |
| MRNA | 177.5 | 1.09 | 197.28 | 5 (2026-10-02) | 88.28% | 0.61% | 1.31x |
| MRNA | 165.0 | 20.33 | 197.28 | 80 (2027-01-15) | 73.14% | 12.32% | 1.31x |
| MRNA | 160.0 | 13.85 | 197.28 | 60 (2026-12-18) | 76.44% | 8.66% | 1.31x |
| MRNA | 160.0 | 18.37 | 197.28 | 80 (2027-01-15) | 75.17% | 11.48% | 1.30x |
| MRNA | 170.0 | 3.15 | 197.28 | 15 (2026-10-16) | 83.45% | 1.85% | 1.29x |
| MRNA | 170.0 | 32.25 | 197.28 | 125 (2027-03-19) | 71.09% | 18.97% | 1.29x |
| MRNA | 150.0 | 7.26 | 197.28 | 40 (2026-11-20) | 83.25% | 4.84% | 1.28x |
| MRNA | 172.5 | 3.1 | 197.28 | 15 (2026-10-16) | 82.62% | 1.80% | 1.28x |
| MRNA | 155.0 | 11.85 | 197.28 | 60 (2026-12-18) | 78.86% | 7.65% | 1.28x |
| MRNA | 150.0 | 10.4 | 197.28 | 60 (2026-12-18) | 80.99% | 6.93% | 1.26x |
| MRNA | 150.0 | 13.85 | 197.28 | 80 (2027-01-15) | 79.41% | 9.23% | 1.25x |
| MRNA | 160.0 | 23.65 | 197.28 | 125 (2027-03-19) | 74.50% | 14.78% | 1.23x |
| MRNA | 175.0 | 0.79 | 197.28 | 5 (2026-10-02) | 91.02% | 0.45% | 1.23x |
| MRNA | 150.0 | 20.2 | 197.28 | 125 (2027-03-19) | 77.84% | 13.47% | 1.22x |
| MRNA | 172.5 | 0.57 | 197.28 | 5 (2026-10-02) | 93.18% | 0.33% | 1.17x |